180 related articles for article (PubMed ID: 16042327)
1. Growth hormone improves bone mineral content in children with cystic fibrosis.
Hardin DS; Ahn C; Prestidge C; Seilheimer DK; Ellis KJ
J Pediatr Endocrinol Metab; 2005 Jun; 18(6):589-95. PubMed ID: 16042327
[TBL] [Abstract][Full Text] [Related]
2. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis-related bone disease explored using a four step algorithm.
Brookes DS; Briody JN; Munns CF; Davies PS; Hill RJ
J Cyst Fibros; 2015 Jan; 14(1):127-34. PubMed ID: 25169790
[TBL] [Abstract][Full Text] [Related]
4. Normal bone mineral density in cystic fibrosis.
Hardin DS; Arumugam R; Seilheimer DK; LeBlanc A; Ellis KJ
Arch Dis Child; 2001 Apr; 84(4):363-8. PubMed ID: 11259244
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of growth hormone use in adolescents with cystic fibrosis.
Hardin DS; Ferkol T; Ahn C; Dreimane D; Dyson M; Morse M; Prestidge C; Rice J; Seilheimer DK
Clin Endocrinol (Oxf); 2005 May; 62(5):560-6. PubMed ID: 15853825
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial.
Hardin DS; Adams-Huet B; Brown D; Chatfield B; Dyson M; Ferkol T; Howenstine M; Prestidge C; Royce F; Rice J; Seilheimer DK; Steelman J; Shepherds R
J Clin Endocrinol Metab; 2006 Dec; 91(12):4925-9. PubMed ID: 17018651
[TBL] [Abstract][Full Text] [Related]
7. Deficits in bone mineral content in children and adolescents with cystic fibrosis are related to height deficits.
Kelly A; Schall JI; Stallings VA; Zemel BS
J Clin Densitom; 2008; 11(4):581-9. PubMed ID: 18757221
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone decreases protein catabolism in children with cystic fibrosis.
Hardin DS; Ellis KJ; Dyson M; Rice J; McConnell R; Seilheimer DK
J Clin Endocrinol Metab; 2001 Sep; 86(9):4424-8. PubMed ID: 11549686
[TBL] [Abstract][Full Text] [Related]
9. Variation of bone acquisition during growth hormone treatment in children can be explained by proteomic biomarkers, bone formation markers, body composition and nutritional factors.
Swolin-Eide D; Andersson B; Hellgren G; Magnusson P; Albertsson-Wikland K
Bone; 2018 Nov; 116():144-153. PubMed ID: 30071306
[TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study.
Shalet SM; Shavrikova E; Cromer M; Child CJ; Keller E; Zapletalová J; Moshang T; Blum WF; Chipman JJ; Quigley CA; Attanasio AF
J Clin Endocrinol Metab; 2003 Sep; 88(9):4124-9. PubMed ID: 12970274
[TBL] [Abstract][Full Text] [Related]
11. Bone status in cystic fibrosis.
Sood M; Hambleton G; Super M; Fraser WD; Adams JE; Mughal MZ
Arch Dis Child; 2001 Jun; 84(6):516-20. PubMed ID: 11369574
[TBL] [Abstract][Full Text] [Related]
12. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
[TBL] [Abstract][Full Text] [Related]
13. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
14. Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial.
Erdtsieck RJ; Pols HA; Valk NK; van Ouwerkerk BM; Lamberts SW; Mulder P; Birkenhäger JC
Clin Endocrinol (Oxf); 1995 Nov; 43(5):557-65. PubMed ID: 8548940
[TBL] [Abstract][Full Text] [Related]
15. Importance of lean mass in the interpretation of total body densitometry in children and adolescents.
Högler W; Briody J; Woodhead HJ; Chan A; Cowell CT
J Pediatr; 2003 Jul; 143(1):81-8. PubMed ID: 12915829
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area.
Ahmed SF; Horrocks IA; Patterson T; Zaidi S; Ling SC; McGrogan P; Weaver LT
J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):276-80. PubMed ID: 15076625
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial.
Hardin DS; Ellis KJ; Dyson M; Rice J; McConnell R; Seilheimer DK
J Pediatr; 2001 Nov; 139(5):636-42. PubMed ID: 11713439
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
[TBL] [Abstract][Full Text] [Related]
20. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry.
Högler W; Briody J; Moore B; Garnett S; Lu PW; Cowell CT
J Clin Endocrinol Metab; 2004 Jan; 89(1):193-9. PubMed ID: 14715849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
